Welsh Conference 2021 | Diabetes on the Net

Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

New horizons in diabetes care

Book your place for our upcoming virtual conference

13 May 2021

Next event starting shortly. Already registered?

The Primary Care Diabetes Society (PCDS)

12th annual Welsh Conference

The Primary Care Diabetes Society (PCDS) is pleased to announce this year’s Welsh conference, which will be taking place in a virtual format.

Organised by the PCDS, the only association solely committed to the needs of primary care diabetes, this virtual conference will examine diabetes care from a Welsh perspective. Through a mixture of lectures and masterclasses, the conference will provide practical guidance to healthcare professionals, focusing on those issues that impact the most on everyday diabetes practice in Wales and beyond.

We are delighted to be delivering an event that we feel provides an invaluable opportunity for us to come together, virtually, and cover the real core issues in day-to-day diabetes care delivery in Wales.

We look forward to welcoming you online.

Welsh Representatives on the PCDS Committee 

This fast-paced, interactive conference combines latest clinical guidance, research, case studies and hot topics in diabetes, including lessons learned from COVID-19 and much more

  • Ask the experts your burning questions through the LIVE Q&A at the end of each session
  • Log on anytime during the day from the comfort of your own home to view the sessions ​
  • Don’t worry if you miss something, all of the content will be available on-demand 

Agenda

09:00

Introduction

09:10

Diabetes in Wales

  • An update on the landscape of diabetes care in 2021

15 min break

09:55

Trulicity® (dulaglutide): Significant Efficacy, Simply Achieved, and New Higher Dose Data

Symposium

  • This content is for UK & ROI Healthcare Professionals only. Lilly has provided sponsorship for the delivery of the conference and have only had input into the symposium sessions which they have sponsored.
  • Click here for Trulicity® (dulaglutide) Prescribing Information and Adverse Event Reporting

 

         PP-LD-GB-1190    April 2021

15 min break

10:40

Moving diabetes care forwards

  • Considerations for establishing the priorities in delivering diabetes care, catching up
  • Lessons learnt from COVID-19, which we can take forwards
  • Practical ideas and quality improvement activities to consider for your own practice 

15 min break

11:25

‘In Practice’ masterclasses | Rotation 1

1. Lifestyle medicine

  • The importance of lifestyle interventions
  • What the latest evidence tells us

2. The practicalities of insulin in primary care

  • Mastering the basics
  • How to discuss insulin initiation in people with type 2 diabetes
  • What’s different about the latest insulins?

3. Complex cases – diabetes and the gut

  • A series of cases offering practical advice for the care of complex patients

4. Remote consultations for Type 2 diabetes- supporting more effective clinical management

  • Session organised and supported by Abbott Laboratories Ltd.

15 min break

12:20

‘In Practice’ masterclasses | Rotation 2

1. Lifestyle medicine

  • The importance of lifestyle interventions
  • What the latest evidence tells us

2. The practicalities of insulin in primary care

  • Mastering the basics
  • How to discuss insulin initiation in people with type 2 diabetes
  • What’s different about the latest insulins?

3. Complex cases – cardiometabolic renal

  • A series of cases offering practical advice for the care of complex patients

15 min break

13:15

Shorts:

  • Retinal screening 

13:30

Shorts:

  • Lipid management

15 min break

14:00

Diabetes and heart failure: A risk worth managing

  • AstraZeneca promotional symposium

15 min break

14:45

Diabetes Distilled

  • Breaking stories from the weeks and months leading up to the conference

15:15

Concluding remarks

Speakers

Pam_CRL.png

Pam Brown

GP, Swansea

Iain Cranston

Iain Cranston

Consultant Physician, Diabetes and Endocrinology, Queen Alexandra Hospital, Portsmouth

Sarah Davies_cropped

Sarah Davies

GP Partner, Cardiff

Dr-Kevin-Fernando.jpg

Kevin Fernando

GPwSI in Diabetes and Medical Education, North Berwick

Shahzada Khan

Shahzada Khan

GP Principal, Newham

Julie_lewis

Julie Lewis

Nurse Consultant, Primary Care Diabetes, Central Area, North Wales

Consultant in Diabetes, Prince Phillip Hospital, Llanelli

Akhila Mallipedhi

Consultant in Diabetes, Prince Phillip Hospital, Llanelli

David_CRL

David Millar-Jones​​

GP, Cwmbran

JULIA._Platts

Julia Platts

Consultant Diabetologist and National Clinical Lead for Diabetes in Wales, Cardiff

Rebecca Thomas

Rebecca Thomas

Senior Research Officer

Patrick Wainwright

Patrick Wainwright

Consultant in Chemical Pathology and Metabolic Medicine, North Wales

New Project (65)

John Wakeling

GP, Cardiff

New Project (64)

Zaheer Yousef

Consultant Cardiologist, Cardiff

Conference sponsors

GOLD SPONSOR

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

AstraZeneca operates in five different locations in the UK, where around 8,300 employees work in research and development, manufacturing, supply, sales and marketing. We supply 40 different medicines to the NHS. The UK is also an important location for AstraZeneca’s clinical trials; in 2018, there were 201 trials at 376 centres in the UK, involving over 7,000 patients. For more information, please visit www.astrazeneca.co.uk

SILVER SPONSOR

Eli Lilly and Company Ltd​

Lilly has been a global leader in diabetes care since 1923, when we introduced the world’s first commercial insulin. Today, we are building upon this heritage by working to meet the diverse needs of people living with diabetes and those who care for them. Through research and collaboration, a wide range of therapies, and a continued determination to provide real solutions—from medicines to support programs and more—we strive to make life better for all those affected by diabetes around the world. For more information, visit www.lillydiabetes.co.uk​

MASTERCLASS SPONSOR

Abbott’s Diabetes Care Division

Abbott’s diabetes care division is a global leader in glucose monitoring systems. We are dedicated to helping people manage their diabetes and achieve their best health outcomes with innovative technology, such as the FreeStyle Libre system, allowing patients to monitor their glucose with a quick and easy scan. For more information, such as how the FreeStyle Libre system and our digital health tools support healthcare professionals and their patients visit www.freestylediabetes.co.uk

BRONZE SPONSOR

Novo Nordisk

At Novo Nordisk, our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. Novo Nordisk is a leading global healthcare company, founded in 1923 and our heritage has given us experience and capabilities that enable us to expand access to our medicines and work to prevent and ultimately cure disease by pioneering scientific breakthroughs. Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 80 countries and markets its products in around 170 countries. Every day, millions of people all over the world rely on our products. For more information visit www.novonordisk.co.uk

Taking place on:

This conference was developed by the PCDS in conjunction with OmniaMed Communications. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.